As the government ramps up its response to the Zika virus scare, Bethlehem, Pa.-based Orasure Technologies Inc. will receive up to $16.6 million from the U.S. Department of Health and Human Services to develop a rapid molecular diagnostic that tests for the disease's antibodies. The funding comes from the agency's Biomedical Advanced Research and Development Authority. Read More
